News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
McHale Duncan
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/09/2023 |
4
| McHale Duncan (Chief Medical Officer) has filed a Form 4 on Evelo Biosciences, Inc.|
Txns:
| Sold 3,434 shares
@ $9.51, valued at
$32.7k
Exercised 6,500 restricted stock units
@ $0 |
|
| 05/10/2023 |
4
| McHale Duncan (Chief Medical Officer) has filed a Form 4 on Evelo Biosciences, Inc.|
Txns:
| Sold 66,730 shares
@ $0.1255, valued at
$8.4k
|
|
| 05/09/2023 |
4
| McHale Duncan (Chief Medical Officer) has filed a Form 4 on Evelo Biosciences, Inc.|
Txns:
| Exercised 130,000 restricted stock units
@ $0 |
|
| 02/09/2023 |
4
| McHale Duncan (Chief Medical Officer) has filed a Form 4 on Evelo Biosciences, Inc.|
Txns:
| Granted 520,000 restricted stock units
@ $0 |
|
| 05/31/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/21/2022 |
4
| McHale Duncan (Chief Medical Officer) has filed a Form 4 on Evelo Biosciences, Inc.|
Txns:
| Granted 100,000 options to buy
@ $5.05, valued at
$505k
|
|
| 01/29/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/30/2020 |
4
| McHale Duncan (Chief Medical Officer) has filed a Form 4 on Evelo Biosciences, Inc.|
Txns:
| Granted 117,000 options to buy
@ $7.06, valued at
$826k
|
|
| 05/10/2018 |
4
| McHale Duncan (Chief Medical Officer) has filed a Form 4 on Evelo Biosciences, Inc.|
Txns:
| Granted 79,052 options
@ $16, valued at
$1.3M
|
|
|
|